Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California. more
Time Frame | BMRA | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.68% | -3.72% | -0.05% |
1-Month Return | -7.46% | -1.85% | 2.75% |
3-Month Return | -3.55% | -11.4% | 7.4% |
6-Month Return | -47.46% | -4.41% | 10.47% |
1-Year Return | -81.21% | 4.13% | 27.57% |
3-Year Return | -92.25% | 0.3% | 29.56% |
5-Year Return | -88.73% | 36.62% | 89.3% |
10-Year Return | -63.1% | 106.81% | 206.09% |
May '20 | May '21 | May '22 | May '23 | May '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 6.69M | 7.20M | 18.87M | 5.34M | 5.42M | [{"date":"2020-05-31","value":35.46,"profit":true},{"date":"2021-05-31","value":38.15,"profit":true},{"date":"2022-05-31","value":100,"profit":true},{"date":"2023-05-31","value":28.29,"profit":true},{"date":"2024-05-31","value":28.69,"profit":true}] |
Cost of Revenue | 4.91M | 6.70M | 15.89M | 4.89M | 4.80M | [{"date":"2020-05-31","value":30.9,"profit":true},{"date":"2021-05-31","value":42.17,"profit":true},{"date":"2022-05-31","value":100,"profit":true},{"date":"2023-05-31","value":30.79,"profit":true},{"date":"2024-05-31","value":30.23,"profit":true}] |
Gross Profit | 1.78M | 496.98K | 2.98M | 446.00K | 611.00K | [{"date":"2020-05-31","value":59.84,"profit":true},{"date":"2021-05-31","value":16.69,"profit":true},{"date":"2022-05-31","value":100,"profit":true},{"date":"2023-05-31","value":14.98,"profit":true},{"date":"2024-05-31","value":20.52,"profit":true}] |
Gross Margin | 26.62% | 6.90% | 15.78% | 8.35% | 11.28% | [{"date":"2020-05-31","value":100,"profit":true},{"date":"2021-05-31","value":25.93,"profit":true},{"date":"2022-05-31","value":59.26,"profit":true},{"date":"2023-05-31","value":31.38,"profit":true},{"date":"2024-05-31","value":42.38,"profit":true}] |
Operating Expenses | 4.18M | 7.02M | 7.51M | 7.67M | 6.98M | [{"date":"2020-05-31","value":54.57,"profit":true},{"date":"2021-05-31","value":91.53,"profit":true},{"date":"2022-05-31","value":97.94,"profit":true},{"date":"2023-05-31","value":100,"profit":true},{"date":"2024-05-31","value":90.99,"profit":true}] |
Operating Income | (2.40M) | (6.52M) | (4.53M) | (7.22M) | (6.37M) | [{"date":"2020-05-31","value":-240284800,"profit":false},{"date":"2021-05-31","value":-652247500,"profit":false},{"date":"2022-05-31","value":-453396400,"profit":false},{"date":"2023-05-31","value":-722300000,"profit":false},{"date":"2024-05-31","value":-636700000,"profit":false}] |
Total Non-Operating Income/Expense | 142.37K | 132.99K | 53.28K | 267.00K | 862.00K | [{"date":"2020-05-31","value":16.52,"profit":true},{"date":"2021-05-31","value":15.43,"profit":true},{"date":"2022-05-31","value":6.18,"profit":true},{"date":"2023-05-31","value":30.97,"profit":true},{"date":"2024-05-31","value":100,"profit":true}] |
Pre-Tax Income | (2.33M) | (6.46M) | (4.51M) | (7.09M) | (5.94M) | [{"date":"2020-05-31","value":-233166400,"profit":false},{"date":"2021-05-31","value":-645597900,"profit":false},{"date":"2022-05-31","value":-450732500,"profit":false},{"date":"2023-05-31","value":-708900000,"profit":false},{"date":"2024-05-31","value":-593600000,"profit":false}] |
Income Taxes | 7.39K | 13.06K | 23.72K | 51.00K | 42.00K | [{"date":"2020-05-31","value":14.49,"profit":true},{"date":"2021-05-31","value":25.6,"profit":true},{"date":"2022-05-31","value":46.51,"profit":true},{"date":"2023-05-31","value":100,"profit":true},{"date":"2024-05-31","value":82.35,"profit":true}] |
Income After Taxes | (2.34M) | (6.47M) | (4.53M) | (7.14M) | (5.98M) | [{"date":"2020-05-31","value":-233905400,"profit":false},{"date":"2021-05-31","value":-646903600,"profit":false},{"date":"2022-05-31","value":-453104400,"profit":false},{"date":"2023-05-31","value":-714000000,"profit":false},{"date":"2024-05-31","value":-597800000,"profit":false}] |
Income From Continuous Operations | (2.34M) | (6.47M) | (4.53M) | (7.14M) | (5.98M) | [{"date":"2020-05-31","value":-233905400,"profit":false},{"date":"2021-05-31","value":-646903600,"profit":false},{"date":"2022-05-31","value":-453104400,"profit":false},{"date":"2023-05-31","value":-714000000,"profit":false},{"date":"2024-05-31","value":-597800000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-05-31","value":"-","profit":true},{"date":"2021-05-31","value":"-","profit":true},{"date":"2022-05-31","value":"-","profit":true},{"date":"2023-05-31","value":"-","profit":true},{"date":"2024-05-31","value":"-","profit":true}] |
Net Income | (2.34M) | (6.47M) | (4.53M) | (7.14M) | (5.98M) | [{"date":"2020-05-31","value":-233905400,"profit":false},{"date":"2021-05-31","value":-646903600,"profit":false},{"date":"2022-05-31","value":-453104400,"profit":false},{"date":"2023-05-31","value":-714000000,"profit":false},{"date":"2024-05-31","value":-597800000,"profit":false}] |
EPS (Diluted) | (0.23) | (0.54) | (0.36) | (0.51) | (0.39) | [{"date":"2020-05-31","value":-23,"profit":false},{"date":"2021-05-31","value":-54,"profit":false},{"date":"2022-05-31","value":-36,"profit":false},{"date":"2023-05-31","value":-51,"profit":false},{"date":"2024-05-31","value":-39.46,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BMRA | |
---|---|
Cash Ratio | 1.31 |
Current Ratio | 3.00 |
Quick Ratio | 2.09 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BMRA | |
---|---|
ROA (LTM) | -38.54% |
ROE (LTM) | -76.48% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BMRA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.32 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.68 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BMRA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.96 |
P/B | 0.99 |
Price/FCF | NM |
EV/R | 0.57 |
EV/Ebitda | NM |
PEG | NM |
Biomerica Inc (BMRA) share price today is $0.31
Yes, Indians can buy shares of Biomerica Inc (BMRA) on Vested. To buy Biomerica Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BMRA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Biomerica Inc (BMRA) via the Vested app. You can start investing in Biomerica Inc (BMRA) with a minimum investment of $1.
You can invest in shares of Biomerica Inc (BMRA) via Vested in three simple steps:
The 52-week high price of Biomerica Inc (BMRA) is $1.51. The 52-week low price of Biomerica Inc (BMRA) is $0.24.
The price-to-earnings (P/E) ratio of Biomerica Inc (BMRA) is
The price-to-book (P/B) ratio of Biomerica Inc (BMRA) is 0.99
The dividend yield of Biomerica Inc (BMRA) is 0.00%
The market capitalization of Biomerica Inc (BMRA) is $5.46M
The stock symbol (or ticker) of Biomerica Inc is BMRA